Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
24.80
+1.22 (5.17%)
Apr 14, 2026, 3:48 PM EDT - Market open

10x Genomics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
642.82610.79618.73516.41490.49
Revenue Growth (YoY)
5.24%-1.28%19.81%5.28%64.13%
Cost of Revenue
198.94196.3209.41120.3974.09
Gross Profit
443.88414.48409.31396.02416.4
Selling, General & Admin
316.13344.34343.33298.3257.56
Research & Development
238.63264.7270.33265.67211.75
Other Operating Expenses
49.9-60.98--0.66
Total Operating Expenses
604.67609.04674.64563.97468.65
Operating Income
-60.99-194.56-265.33-167.94-52.25
Interest Income
20.0518.9316.896.650.21
Interest Expense
--0-0.03-0.48-0.87
Other Non-Operating Income (Expense)
1.03-2.07-0.29-0.2-0.8
Total Non-Operating Income (Expense)
21.0816.8616.575.97-1.46
Pretax Income
-39.91-177.7-248.76-161.97-53.72
Provision for Income Taxes
3.644.936.344.034.51
Net Income
-43.54-182.63-255.1-166-58.22
Net Income to Common
-43.54-182.63-255.1-166-58.22
Shares Outstanding (Basic)
125120117114110
Shares Outstanding (Diluted)
125120117114110
Shares Change (YoY)
3.57%2.80%2.90%3.18%9.09%
EPS (Basic)
-0.35-1.52-2.18-1.46-0.53
EPS (Diluted)
-0.35-1.52-2.18-1.46-0.53
Shares Outstanding
127.69122.29119.1115.2111.71
Free Cash Flow
130.12-5.73-63.8-165.27-122.65
Free Cash Flow Per Share
1.04-0.05-0.54-1.45-1.11
Gross Margin
69.05%67.86%66.15%76.69%84.89%
Operating Margin
-9.49%-31.85%-42.88%-32.52%-10.65%
Profit Margin
-6.77%-29.90%-41.23%-32.15%-11.87%
FCF Margin
20.24%-0.94%-10.31%-32.00%-25.01%
EBITDA
-17.17-150.85-221.71-134.94-24
EBITDA Margin
-2.67%-24.70%-35.83%-26.13%-4.89%
EBIT
-60.99-194.56-265.33-167.94-52.25
EBIT Margin
-9.49%-31.85%-42.88%-32.52%-10.65%
Effective Tax Rate
-9.11%-2.77%-2.55%-2.49%-8.39%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q